Link to NASCSA testimony:
Link to webinar:
January 30, 2018
NASCSA testifies before FDA, Opioid Policy Steering Committee - NASCSA Statement for the Record as presented by Barbara Carter
Mr. Chair and Committee Members, the National Association of State Controlled Substances Authorities appreciates the opportunity to share with the Committee the work that our organization, states and other stakeholders are executing in partnership to address the opioid crisis. We commend the FDA and its a hearing to receive stakeholder input on how the FDA might under its authority, improve the safe use of opioid analgesics by curbing overprescribing to decrease the occurrence of new addictions and limit misuse and abuse of opioid analgesics.
To view complete testimony - Click link at top of this page